(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SKINVIVA REGENERATIVE RADIOTHERAPY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

SKINVIVA REGENERATIVE RADIOTHERAPY

ST13

US500000079317444

Class

9, 10, 42, 44

Filing

79317444

Registration

7244858

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

49

Latest update

02/27/2026

Trademark type

Combined

Nice classes

9, 10, 42, 44

Filing date

03/10/2021

Registration date

12/19/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/19/2023

Last transaction

02/27/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

16

Owner location

GB

Examiner

HILLIARD, JESSICA LYNN

Law office

N20

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of a circular design made up of eight leaf like designs. The leaves alternate in color starting from the top and going clockwise: grey, blue, grey, green, grey, orange, grey, and red. Below the design is the stacked wording "SKINVIVA" and "REGENERATIVE RADIOTHERAPY" in grey.

Holders and representatives

Holders

Genesis Specialist Care Holding UK Limited

Representatives

Andrew S. Ehard

Technical classification

Nice Classes

Class 9Class 10Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Downloadable computer software for use in relation to pre-cancer treatment servicescancer treatment servicesradiation therapy servicessoftware for assessing the severity of skin cancerization and damage; downloadable software applications for use in relation to pre-cancer treatment servicescancer treatment servicesradiation therapy servicessoftware for assessing the severity of skin cancerization and damage; electronic publicationsdownloadable magazinesbooksnewslettersarticles in the field of medicine; electronic publicationsdownloadable magazinesbooksnewslettersarticles featuring medical matters; digital downloadable electronic publications in the nature of questionnaires for medical assessments; downloadable computer software and software applications for the diagnosismonitoring and treatment of medical and health conditions; downloadable computer software and software applications for the diagnosismonitoring and treatment of skin conditions; downloadable computer software and software applications for the management of the medical patient experience; downloadable computer software and software applications for providing medical and health information; downloadable computer software and software applications for providing medical and health information relating to skin; downloadable computer software and software applications for harmonized care management of medical patients; downloadable computer software and software applications for medical patient administration

Class 10

Medical apparatus for use in administering radiation therapy; medical radiation apparatus in the nature of bolus for use in radiation therapy

Class 42

Software as a service (SaaS) services featuring software for use in relation to pre-cancer treatment servicescancer treatment servicesradiation therapy servicesnon-downloadable software for assessing the severity of skin cancerization and damage; software as a service (SAAS) services featuring software for the diagnosismonitoring and treatment of medical and health conditions; software as a service (SAAS) services featuring software for the diagnosismonitoring and treatment of skin conditions; software as a service (Saas) services software for the management of the medical patient experience; software as a service (SaaS) services featuring software for providing medical and health content; software as a service (SaaS) services featuring software for providing medical and health content relating to skin; software as a service (SaaS) services featuring software for harmonised care management of medical patients; software as a service (SaaS) services featuring software for medical patient administration

Class 44

Radiation oncology services; radiation oncology therapy services

Publications

History of USPTO decisions and trademark events.

49 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

02/26/2026

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

04/22/2024

FICS

FINAL DISPOSITION NOTICE SENT TO IB

03/27/2024

FIMP

FINAL DISPOSITION PROCESSED

03/27/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

03/19/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/19/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

12/19/2023

GPNX

NOTIFICATION PROCESSED BY IB

10/03/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/03/2023

PUBO

PUBLISHED FOR OPPOSITION

10/03/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

09/13/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

09/13/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/13/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/25/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/16/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/16/2023

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

08/16/2023

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

04/21/2023

GNFR

FINAL REFUSAL E-MAILED

04/21/2023

CNFR

FINAL REFUSAL WRITTEN

04/21/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/24/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/24/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/24/2023

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

01/31/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

01/11/2023

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

01/11/2023

RFNP

REFUSAL PROCESSED BY IB

11/07/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/12/2022

GNRT

NON-FINAL ACTION E-MAILED

10/12/2022

CNRT

NON-FINAL ACTION WRITTEN

10/12/2022

NREP

NEW REPRESENTATIVE AT IB RECEIVED

08/14/2022

LIME

LIMITATION FROM THE IB - REQUEST EXAM REVIEW

07/25/2022

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

06/21/2022

GNSL

LETTER OF SUSPENSION E-MAILED

06/21/2022

CNSL

SUSPENSION LETTER WRITTEN

06/21/2022

DOCK

ASSIGNED TO EXAMINER

05/09/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/05/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/04/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/04/2022

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

04/23/2022

RFNT

REFUSAL PROCESSED BY IB

11/23/2021

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

11/04/2021

RFRR

REFUSAL PROCESSED BY MPU

11/04/2021

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

10/07/2021

CNRT

NON-FINAL ACTION WRITTEN

10/06/2021

DOCK

ASSIGNED TO EXAMINER

10/06/2021

MAFR

APPLICATION FILING RECEIPT MAILED

08/13/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/09/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

08/05/2021

Continuous trademark protection

Get notified about every new filing that threatens SKINVIVA REGENERATIVE RADIOTHERAPY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.